HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Angioarchitecture of pulmonary arteriovenous malformations: an important consideration before embolotherapy.

Abstract
Seventeen patients with 91 pulmonary arteriovenous malformations were evaluated by superselective angiography. Seventy-two (79%) of the malformations consisted of a simple type characterized by a single feeding artery draining into a bulbous, nonseptated aneurysmal communication with a single draining vein. The other 19 (21%) were complex, consisting of two or more pulmonary artery branches communicating with a bulbous septated aneurysmal part with two or more draining veins. Two patients had diffuse pulmonary arteriovenous malformations confined to multiple lobes of the lung. Balloon embolotherapy was effective in permanently obliterating the malformations in 14 patients treated. Therapy provided a sustained rise in arterial PO2 in the sitting position from a mean value of 44 mm Hg before occlusion to 65 mm Hg after occlusion. In three patients the process was too diffuse and/or the malformations too large for therapy to be effective. Complex pulmonary arteriovenous malformations required occlusion of all feeding arteries. Balloon embolotherapy provided an effective treatment for pulmonary arteriovenous malformations regardless of anatomic type.
AuthorsR I White Jr, S E Mitchell, K H Barth, S L Kaufman, S Kadir, R Chang, P B Terry
JournalAJR. American journal of roentgenology (AJR Am J Roentgenol) Vol. 140 Issue 4 Pg. 681-6 (Apr 1983) ISSN: 0361-803X [Print] United States
PMID6601370 (Publication Type: Journal Article)
Topics
  • Adolescent
  • Adult
  • Aged
  • Angiography
  • Arteriovenous Malformations (diagnostic imaging, pathology, therapy)
  • Child
  • Child, Preschool
  • Embolization, Therapeutic (methods)
  • Female
  • Humans
  • Lung (blood supply)
  • Male
  • Middle Aged
  • Pulmonary Artery (abnormalities)
  • Pulmonary Veins (abnormalities)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: